<?xml version="1.0" encoding="UTF-8"?>
<p>In general, the above purposes go in line with increasing the number of excipients registered in the database to be useful in practical research. Therefore, the following selection criteria were considered for excipients of interest [
 <xref rid="B2-pharmaceutics-13-00387" ref-type="bibr">2</xref>]:
 <list list-type="order">
  <list-item>
   <p>Excipients known to be toxic/have general safety issues.</p>
  </list-item>
  <list-item>
   <p>Frequency of appearance as contaminants or toxics in paediatrics (where applicable).</p>
  </list-item>
  <list-item>
   <p>Evidence in the toxicity literature in paediatrics. The above criteria were applied to identify excipients for inclusion in the STEP database. Excipients were shortlisted/prioritized through surveys within EU and US PFI members.</p>
  </list-item>
 </list>
</p>
